Magellan Health, Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

$MGLN
Hospital/Nursing Management
Health Care
Get the next $MGLN alert in real time by email
MAGELLAN HEALTH INC0000019411false00000194112021-11-052021-11-05

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15 (D) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported):

November 5, 2021

MAGELLAN HEALTH, INC.

(Exact Name of Registrant as Specified in Charter)

Delaware

1-6639

58-1076937

(State or Other Jurisdiction

(Commission File

(IRS Employer

of Incorporation)

Number)

Identification No.)

4801 E. Washington Street

Phoenix, Arizona

85034

(Address of Principal Executive Offices)

(Zip Code)

Registrant’s telephone number, including area code: (800) 642-1716

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, par value $0.01 per share

MGLN

The NASDAQ Global Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Item 2.02. Results of Operations and Financial Condition

On November 5, 2021, Magellan Health, Inc. (the “Company”) reported operating results for the quarter ended September 30, 2021. Attached and incorporated herein by reference as Exhibit 99.1 is a copy of the press release dated November 5, 2021.

Item 9.01. Financial Statements, Pro Forma Financial Information and Exhibits

(a)  Financial Statements of business acquired:              Not applicable.

(b)  Pro forma financial information:                  Not applicable.

(d)  Exhibits:See Exhibit Index.

2

Exhibit Index

Exhibit Number

   

Description of Exhibit

99.1

Press release dated November 5, 2021.

104

Cover Page Interactive Data File (embedded within the Inline XBRL document).

3

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

MAGELLAN HEALTH, INC.

Date: November 5, 2021

By:

/s/ David P. Bourdon

Name:   David P. Bourdon

Title:     Chief Financial Officer

4

Get the next $MGLN alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$MGLN

DatePrice TargetRatingAnalyst
More analyst ratings

$MGLN
Press Releases

Fastest customizable press release news feed in the world

See more
  • The Journey Venture Studio Appoints First Four Board Members

    Notable Seasoned Entrepreneurs Will Support Inaugural Founders-In-Residence Cohort and the Development of Future Disruptive Healthcare Startups in Phoenix PHOENIX, July 24, 2023 /PRNewswire-PRWeb/ -- The Journey Venture Studio announced today the appointment of the first four members to its board of directors. Each board member was sought out as a mission-aligned partner as the studio prepares to launch its first Founder in Residence Cohort. The first four board members include: Heidi Jannenga, WebPT Co-founder & Chief Clinical Officer Jason Wood, Managing Director with Morgan Stanley Investment Management's Next Level Fund Andy Lombard, CEO of Arizona Venture Development Corporation (AVC) J

    $CNC
    $MGLN
    Medical Specialities
    Health Care
    Hospital/Nursing Management
  • Concerned Shareholders of Cano Health Nominate Highly Qualified, Independent Director Candidates and Propose Removal of Dr. Marlow Hernandez from Board for Cause

    Group Details the Case for Urgent Change at Cano Following an Extended Period of Underperformance, Failed Capital Allocation, and Extremely Poor Governance and Strategic Execution Urges Stockholders to WITHHOLD Support for Incumbent Directors as Parties Await a Resolution of Litigation to Compel Company to Reopen Window for Nominating Director Candidates and Making Proposals Elliot Cooperstone, Lewis Gold and Barry Sternlicht (collectively with certain of their affiliates, the "Group," "us" or "we"), who recently resigned as members of the Board of Directors (the "Board") of Cano Health, Inc. ("Cano" or the "Company") (NYSE:CANO), today announced that they have submitted a notice to the

    $BKD
    $CANO
    $CIVI
    $EHC
    Hospital/Nursing Management
    Health Care
    Medical/Nursing Services
    Oil & Gas Production
  • Magellan Health Opens 24-hour Crisis Line for Individuals Impacted by Hurricane Ian

    Consultation and resources available at no cost to local community Magellan Health, Inc. today announced that it has opened a complimentary 24-hour crisis line for individuals impacted by the aftermath of Hurricane Ian. The toll-free number to access free, confidential consultation services is 1-800-327-7451. Magellan confidential consultation services are offered at no charge to the community to assist individuals as they work to cope with the feelings of fear, sadness, anger, or hopelessness related to these kinds of natural disasters. Crisis line callers may also seek information and guidance to other available resources, such as community-based support. Tip sheets with resources spe

    $MGLN
    Hospital/Nursing Management
    Health Care

$MGLN
Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

See more

$MGLN
SEC Filings

See more

$MGLN
Leadership Updates

Live Leadership Updates

See more
  • The Journey Venture Studio Appoints First Four Board Members

    Notable Seasoned Entrepreneurs Will Support Inaugural Founders-In-Residence Cohort and the Development of Future Disruptive Healthcare Startups in Phoenix PHOENIX, July 24, 2023 /PRNewswire-PRWeb/ -- The Journey Venture Studio announced today the appointment of the first four members to its board of directors. Each board member was sought out as a mission-aligned partner as the studio prepares to launch its first Founder in Residence Cohort. The first four board members include: Heidi Jannenga, WebPT Co-founder & Chief Clinical Officer Jason Wood, Managing Director with Morgan Stanley Investment Management's Next Level Fund Andy Lombard, CEO of Arizona Venture Development Corporation (AVC) J

    $CNC
    $MGLN
    Medical Specialities
    Health Care
    Hospital/Nursing Management
  • Magellan Health Appoints Tom Britt as Chief Information Officer

    Magellan Health, Inc. today announced it has appointed Tom Britt as chief information officer for Magellan Health. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220808005111/en/Tom Britt (Photo: Business Wire) Britt will work closely with Magellan's executive leadership to create, develop and implement information technology strategy and digital solutions while leveraging best practices and delivering data-enhanced products and services through innovative technology platforms. "Tom is a strong leader with over 25 years of significant leadership experience in building innovative digital products and solutions while leading high

    $MGLN
    Hospital/Nursing Management
    Health Care
  • Magellan Health Appoints Dr. Caroline Carney as President of Behavioral Health

      Magellan Health, Inc., one of the nation's leaders in behavioral health, today announced it has appointed Caroline Carney, MD, MSc, FAPM, CPHQ, as president of behavioral health for its subsidiary, Magellan Healthcare. In this key leadership role, Dr. Carney will advance Magellan Health's clinical mission and further position the company's significant leadership capabilities in behavioral health, including collaborative and integrated approaches that enhance member experience across the continuum of care. Dr. Carney will also continue in her role as chief medical officer of Magellan Health, leading the development and implementation of innovative, integrated clinical programs for custo

    $MGLN
    Hospital/Nursing Management
    Health Care

$MGLN
Financials

Live finance-specific insights

See more
  • Magellan Health Reports Third Quarter 2021 Financial Results

    Magellan Health, Inc. (NASDAQ:MGLN) today announced financial results for the third quarter ended September 30, 2021, as summarized below:             Three Months Ended   Nine Months Ended Sept 30   Sept 30 (In millions, except per share amounts)           Continuing Operations     2021         2020     Chg     2021     2020   Chg Net revenue $   1,254.1     $   1,170.1     7.2 %   $ 3,636.5   $ 3,392.6   7.2 % Net (loss) income $   (0.1 )   $   (17.3 )   NM     $ 21.9   $ 28.7   -23.7 % Segment profit [1] $   38.

    $MGLN
    Hospital/Nursing Management
    Health Care
  • Magellan Health Reports Second Quarter 2021 Financial Results

    Magellan Health, Inc. (NASDAQ:MGLN) today announced financial results for the second quarter ended June 30, 2021, as summarized below: Three Months Ended     Six Months Ended June 30     June 30 (In millions, except per share amounts)                         Continuing Operations     2021         2020   Chg         2021       2020   Chg Net revenue $   1,220.8     $   1,100.1   11.0 %   $   2,382.4   $   2,222.5   7.2 % Net income (loss) $   (6.5 )   $   47.1   -113.7 %   $   22.0   $   46.0   -52.1 % Segment profit [1]

    $MGLN
    Hospital/Nursing Management
    Health Care
  • Magellan Health Reports 2020 Financial Results

    PHOENIX--(BUSINESS WIRE)--Magellan Health, Inc. (NASDAQ: MGLN) today announced financial results for the fourth quarter and the year ended December 31, 2020, as summarized below:   Three Months Ended Twelve Months Ended December 31 December 31 (In millions, except per share amounts) Continuing Operations 2020 2019 Chg 2020 2019 Chg Net revenue $ 1,185.0   $ 1,133.8 4.5 % $ 4,577.5 $ 4,565.6 0.3 % Net (loss) income $ (24.7 ) $ 9.5 NM   $ 4.0 $ 12.6 -67.9 % Segment profit [1] $ 11.3   $ 55.9 -79.8 % $ 14

    $MGLN
    Hospital/Nursing Management
    Health Care

$MGLN
Large Ownership Changes

This live feed shows all institutional transactions in real time.

See more